These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 16753022

  • 1. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo.
    Kulkarni NH, Onyia JE, Zeng Q, Tian X, Liu M, Halladay DL, Frolik CA, Engler T, Wei T, Kriauciunas A, Martin TJ, Sato M, Bryant HU, Ma YL.
    J Bone Miner Res; 2006 Jun; 21(6):910-20. PubMed ID: 16753022
    [Abstract] [Full Text] [Related]

  • 2. Human stem cell osteoblastogenesis mediated by novel glycogen synthase kinase 3 inhibitors induces bone formation and a unique bone turnover biomarker profile in rats.
    Gilmour PS, O'Shea PJ, Fagura M, Pilling JE, Sanganee H, Wada H, Courtney PF, Kavanagh S, Hall PA, Escott KJ.
    Toxicol Appl Pharmacol; 2013 Oct 15; 272(2):399-407. PubMed ID: 23872097
    [Abstract] [Full Text] [Related]

  • 3. Fluoride promotes osteoblastic differentiation through canonical Wnt/β-catenin signaling pathway.
    Pan L, Shi X, Liu S, Guo X, Zhao M, Cai R, Sun G.
    Toxicol Lett; 2014 Feb 10; 225(1):34-42. PubMed ID: 24300170
    [Abstract] [Full Text] [Related]

  • 4. GSK-3 inhibition by an orally active small molecule increases bone mass in rats.
    Marsell R, Sisask G, Nilsson Y, Sundgren-Andersson AK, Andersson U, Larsson S, Nilsson O, Ljunggren O, Jonsson KB.
    Bone; 2012 Mar 10; 50(3):619-27. PubMed ID: 22142634
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
    Wang FS, Ko JY, Weng LH, Yeh DW, Ke HJ, Wu SL.
    Life Sci; 2009 Nov 04; 85(19-20):685-92. PubMed ID: 19782693
    [Abstract] [Full Text] [Related]

  • 6. Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor.
    Kulkarni NH, Wei T, Kumar A, Dow ER, Stewart TR, Shou J, N'cho M, Sterchi DL, Gitter BD, Higgs RE, Halladay DL, Engler TA, Martin TJ, Bryant HU, Ma YL, Onyia JE.
    J Cell Biochem; 2007 Dec 15; 102(6):1504-18. PubMed ID: 17520664
    [Abstract] [Full Text] [Related]

  • 7. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
    Amirhosseini M, Madsen RV, Escott KJ, Bostrom MP, Ross FP, Fahlgren A.
    J Cell Physiol; 2018 Mar 15; 233(3):2398-2408. PubMed ID: 28731198
    [Abstract] [Full Text] [Related]

  • 8. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.
    Gambardella A, Nagaraju CK, O'Shea PJ, Mohanty ST, Kottam L, Pilling J, Sullivan M, Djerbi M, Koopmann W, Croucher PI, Bellantuono I.
    J Bone Miner Res; 2011 Apr 15; 26(4):811-21. PubMed ID: 20939016
    [Abstract] [Full Text] [Related]

  • 9. The effects of Liuwei Dihuang on canonical Wnt/β-catenin signaling pathway in osteoporosis.
    Xia B, Xu B, Sun Y, Xiao L, Pan J, Jin H, Tong P.
    J Ethnopharmacol; 2014 Apr 11; 153(1):133-41. PubMed ID: 24530448
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of bone formation in the expanding premaxillary suture with a GSK-3β inhibitor.
    Jiang Y, Liu HX, Guo JJ, Tang GH, Qian YF.
    Oral Dis; 2013 Jan 11; 19(1):73-9. PubMed ID: 22776263
    [Abstract] [Full Text] [Related]

  • 11. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E, Takahashi-Yanaga F, Miwa Y, Hirata M, Watanabe Y, Sato N, Morimoto S, Hirofuji T, Maeda K, Sasaguri T.
    J Bone Miner Res; 2006 Aug 11; 21(8):1307-16. PubMed ID: 16869729
    [Abstract] [Full Text] [Related]

  • 12. Acceleration of bone regeneration by local application of lithium: Wnt signal-mediated osteoblastogenesis and Wnt signal-independent suppression of osteoclastogenesis.
    Arioka M, Takahashi-Yanaga F, Sasaki M, Yoshihara T, Morimoto S, Hirata M, Mori Y, Sasaguri T.
    Biochem Pharmacol; 2014 Aug 15; 90(4):397-405. PubMed ID: 24955980
    [Abstract] [Full Text] [Related]

  • 13. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S.
    J Bone Miner Res; 2007 Jun 15; 22(6):849-59. PubMed ID: 17352644
    [Abstract] [Full Text] [Related]

  • 14. Stretch-induced inhibition of Wnt/beta-catenin signaling in mineralizing osteoblasts.
    Jansen JH, Eijken M, Jahr H, Chiba H, Verhaar JA, van Leeuwen JP, Weinans H.
    J Orthop Res; 2010 Mar 15; 28(3):390-6. PubMed ID: 19780202
    [Abstract] [Full Text] [Related]

  • 15. Leptin promotes osteoblast differentiation and mineralization of primary cultures of vascular smooth muscle cells by inhibiting glycogen synthase kinase (GSK)-3β.
    Zeadin MG, Butcher MK, Shaughnessy SG, Werstuck GH.
    Biochem Biophys Res Commun; 2012 Sep 07; 425(4):924-30. PubMed ID: 22906741
    [Abstract] [Full Text] [Related]

  • 16. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
    Hamidouche Z, Haÿ E, Vaudin P, Charbord P, Schüle R, Marie PJ, Fromigué O.
    FASEB J; 2008 Nov 07; 22(11):3813-22. PubMed ID: 18653765
    [Abstract] [Full Text] [Related]

  • 17. Guava fruit extract and its triterpene constituents have osteoanabolic effect: Stimulation of osteoblast differentiation by activation of mitochondrial respiration via the Wnt/β-catenin signaling.
    Porwal K, Pal S, Dev K, China SP, Kumar Y, Singh C, Barbhuyan T, Sinha N, Sanyal S, Trivedi AK, Maurya R, Chattopadhyay N.
    J Nutr Biochem; 2017 Jun 07; 44():22-34. PubMed ID: 28343085
    [Abstract] [Full Text] [Related]

  • 18. PKR plays a positive role in osteoblast differentiation by regulating GSK-3β activity through a β-catenin-independent pathway.
    Yoshida K, Okamura H, Ochiai K, Hoshino Y, Haneji T, Yoshioka M, Hinode D, Yoshida H.
    Mol Cell Endocrinol; 2012 Sep 25; 361(1-2):99-105. PubMed ID: 22484461
    [Abstract] [Full Text] [Related]

  • 19. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
    Georgiou KR, King TJ, Scherer MA, Zhou H, Foster BK, Xian CJ.
    Bone; 2012 Jun 25; 50(6):1223-33. PubMed ID: 22484100
    [Abstract] [Full Text] [Related]

  • 20. A role for ethanol-induced oxidative stress in controlling lineage commitment of mesenchymal stromal cells through inhibition of Wnt/beta-catenin signaling.
    Chen JR, Lazarenko OP, Shankar K, Blackburn ML, Badger TM, Ronis MJ.
    J Bone Miner Res; 2010 May 25; 25(5):1117-27. PubMed ID: 20200986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.